tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
NVCT
Nuvectis Pharma
RESEARCH TOOLSreports

Nuvectis Pharma (NVCT) Stock News & Sentiment

Compare
114 Followers
Nuvectis Pharma: Buy Rating Backed by NXP900’s Potential to Overcome EGFR/ALK Inhibitor Resistance in NSCLC
Premium
Ratings
Nuvectis Pharma: Buy Rating Backed by NXP900’s Potential to Overcome EGFR/ALK Inhibitor Resistance in NSCLC
10d ago
NVCT
Positive Recommendation on Nuvectis Pharma Driven by Promising Lead Candidate and Milestone Clinical Studies
Premium
Ratings
Positive Recommendation on Nuvectis Pharma Driven by Promising Lead Candidate and Milestone Clinical Studies
11d ago
NVCT
NXP900: A Promising New Standard in Post-TKI NSCLC Treatment
Premium
Ratings
NXP900: A Promising New Standard in Post-TKI NSCLC Treatment
26d ago
NVCT
Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress
Premium
Ratings
Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress
1M ago
NVCT
Nuvectis Pharma Reports Progress in Oncology Drug Development
Premium
Company Announcements
Nuvectis Pharma Reports Progress in Oncology Drug Development
2M ago
NVCT
Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment
2M ago
NVCT
Promising Safety and Efficacy of Nuvectis Pharma’s NXP900 Drives Buy Recommendation
Premium
Ratings
Promising Safety and Efficacy of Nuvectis Pharma’s NXP900 Drives Buy Recommendation
2M ago
NVCT
More NVCT News >

NVCT News on the Web

Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Down 5.33%
AAII
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Up 7.67%
AAII
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Up 7.92%
AAII
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Up 6.35%
AAII
Neutral
Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)
TipRanks News
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Down 6.11%
AAII
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Up 5.66%
AAII
Neutral
Why Nuvectis Pharma, Inc.’s (NVCT) Stock Is Up 6.15%
AAII
Neutral

News Score - Last 7 Days

Neutral
NVCT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NVCT’s Media Buzz Sentiment?
1 articles about NVCT were published this week. In an average week, 1 articles are published.
    What is NVCT’s weekly average amount of articles?
    In an average week, 1 articles about NVCT are published.
      What is NVCT’s News Sentiment?
      50% of articles about NVCT were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        DVAXDynavax
        AGIOAgios Pharma
        ADUSAddus Homecare
        ENSGThe Ensign Group
        NVONovo Nordisk
        Showing the stocks with the most bullish news sentiment over the past week